Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility

Stopped early · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Primary Ovarian Insufficiency, Unexplained Infertility

In brief

The experimental focus of this project is on the interaction of DHEA treatment on pregnancy in women with otherwise unexplained infertility and evidence of premature ovarian aging (POA).

Key facts

Study ID

NCT00650754

Run by

Center for Human Reproduction

People needed

35

Starts

2008-03-01

Expected to finish

2014-03-01

Last updated by the study team

2015-09-30

Who can join

Age: 21 and older, up to 37. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• >= 1 year of infertility
• < 38 years old
• Normal HSG
• Normal Semen analysis (Count >= 20 million/ motility > 50%/ Kruger morph > 14%.
• Regular menses
• Willingness to sign informed consent for study randomization
• Willingness to participate in 8 months of non-IVF will he him treatment.

You may not qualify if…

• Abnormal semen analysis
• Abnormal HSG
• Baseline FSH/E2 within normal age specific criteria
• Medical condition that would contraindicate pregnancy, ovulation induction or general anesthesia
• Family history of significant genetic disease, or factor V leiden thrombophilia
• Inability to present for monitoring visits
• Inability to follow medication instruction
• Desire to undergo other fertility treatments before completing eight months of this trial

Where it is running

• Center for Human Reproduction — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.